Ras alters epithelial-mesenchymal transition in response to TGFβ by reducing actin fibers and cell-matrix adhesion

Cell Cycle

Volumn 8, Issue 2, 2009, Pages 284-298

  Safina, Alfiya F ^a   Varga, Andrea E ^a   Bianchi, Anna ^a   Zheng, Qiao ^a   Kunnev, Dimiter ^a   Liang, Ping ^a   Bakin, Andrei V ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Adhesion; Invasion; Metastasis; Ras oncogene; Smad4; TGF ; Tropomyosin

Indexed keywords

ACTIN; AGAR; INTEGRIN; RAS PROTEIN; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; TROPOMYOSIN;

ARTICLE; CANCER INHIBITION; CELL ADHESION; CELL INVASION; CELL JUNCTION; CELL POLARITY; EPITHELIUM CELL; EXTRACELLULAR MATRIX; GENE CONTROL; MESENCHYME; METASTASIS POTENTIAL; NONHUMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR GROWTH;

ANIMALIA;

EID: 58549105508     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.8.2.7590     Document Type: Article

References (77)

1. Thiery J. Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol 2003; 15:740-6.
2. Zavadil J and Bottinger EP. TGF[beta] and epithelial-to-mesenchymal transitions. Oncogene 2006; 24:5764-74.
3. Miettinen PJ, Ebner R, Lopez AR and Derynck R. TGFbeta induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors. J Cell Biol 1994; 127:2021-36.
4. Oft M, Peli J, Rudaz C, Schwarz H, Beug H and Reichmann E. TGFbeta1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells. Genes Dev 1996; 10:2462-77.
5. Bates RC and Mercurio AM. Tumor Necrosis Factor-{alpha} Stimulates the Epithelial-to-Mesenchymal Transition of Human Colonic Organoids. Mol Biol Cell 2003; 14:1790-800.
6. Huber MA, Azoitei N, Baumann B, Grunert S, Sommer A, Pehamberger H, et al. NF{kappa}B is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression. J Clin Invest 2004; 114:569-81.
7. Piek E, Moustakas A, Kurisaki A, Heldin CH and ten Dijke P. TGF(beta) type I receptor/ALK-5 and Smad proteins mediate epithelial to mesenchymal transdifferentiation in NMuMG breast epithelial cells. J Cell Sci 1999; 112:4557-68.
8. Bakin AV, Safina A, Rinehart C, Daroqui C, Darbary H and Helfman DM. A Critical Role of Tropomyosins in TGF{beta} Regulation of the Actin Cytoskeleton and Cell Motility in Epithelial Cells. Mol Biol Cell 2004; 15:4682-94.
9. Valcourt U, Kowanetz M, Niimi H, Heldin C-H and Moustakas A. TGF{beta} and the Smad Signaling Pathway Support Transcriptomic Reprogramming during Epithelial-Mesenchymal Cell Transition. Mol Biol Cell 2005; 16:1987-2002.
10. Levy L and Hill CS. Smad4 Dependency Defines Two Classes of Transforming Growth Factor {beta} (TGF{beta}) Target Genes and Distinguishes TGF{beta}-Induced Epithelial-Mesenchymal Transition from Its Antiproliferative and Migratory Responses. Mol Cell Biol 2005; 25:8108-25.
11. Kowanetz M, Valcourt U, Bergstrom R, Heldin CH and Moustakas A. Id2 and Id3 define the potency of cell proliferation and differentiation responses to transforming growth factor beta and bone morphogenetic protein. Mol Cell Biol 2004; 24:4241-54.
12. Kondo M, Cubillo E, Tobiume K, Shirakihara T, Fukuda N, Suzuki H, et al. A role for Id in the regulation of TGFbeta-induced epithelial-mesenchymal transdifferentiation. Cell Death Differ 2004; 11:1092-101.
13. Moustakas A and Heldin C-H. Signaling networks guiding epithelial-mesenchymal transitions during embryogenesis and cancer progression. Cancer Science 2007; 98:1512-20.
14. Edme N, Downward J, Thiery J-P and Boyer B. Ras induces NBT-II epithelial cell scattering through the coordinate activities of Rac and MAPK pathways. J Cell Sci 2002; 115:2591-601.
15. Lehmann K, Janda E, Pierreux CE, Rytomaa M, Schulze A, McMahon M, et al. Raf induces TGFbeta production while blocking its apoptotic but not invasive responses: a mechanism leading to increased malignancy in epithelial cells. Genes Dev 2000; 14:2610-22.
16. Safina A, Vandette E and Bakin AV. ALK5 promotes tumor angiogenesis by upregulating matrix metalloproteinase-9 in tumor cells. Oncogene 2007; 26:2407-22.
17. Filmus J, Zhao J and Buick RN. Overexpression of H-ras oncogene induces resistance to the growth-inhibitory action of transforming growth factor beta-1 (TGFbeta1) and alters the number and type of TGFbeta1 receptors in rat intestinal epithelial cell clones. Oncogene 1992; 7:521-6.
18. Kretzschmar M, Doody J, Timokhina I and Massague J. A mechanism of repression of TGFbeta/Smad signaling by oncogenic Ras. Genes Dev 1999; 13:804-16.
19. Saha D, Datta PK and Beauchamp RD. Oncogenic Ras Represses Transforming Growth Factor-beta/Smad Signaling by Degrading Tumor Suppressor Smad4. J Biol Chem 2001; 276:29531-7.
20. Calonge MJ and Massague J. Smad4/DPC4 Silencing and Hyperactive Ras Jointly Disrupt Transforming Growth Factor-beta Antiproliferative Responses in Colon Cancer Cells. J Biol Chem 1999; 274:33637-43.
21. Tian Y-C, Fraser D, Attisano L and Phillips AO. TGF{beta}1-mediated alterations of renal proximal tubular epithelial cell phenotype. Am J Physiol Renal Physiol 2003; 285:130-42.
22. Tian YC and Phillips AO. TGFbeta1-mediated inhibition of HK-2 cell migration. J Am Soc Nephrol 2003; 14:631-40.
23. Savagner P, Yamada KM and Thiery JP. The zinc-finger protein slug causes desmosome dissociation, an initial and necessary step for growth factor-induced epithelial-mesenchymal transition. J Cell Biol 1997; 137:1403-19.
24. Zheng Q, Safina A and Bakin AV. Role of high-molecular weight tropomyosins in TGFbeta-mediated control of cell motility. International Journal of Cancer 2008; 122:78-90.
25. Perry SV. Vertebrate tropomyosin: distribution, properties and function. J Muscle Res Cell Motil 2001; 22:5-49.
26. Pawlak G and Helfman DM. Cytoskeletal changes in cell transformation and tumorigenesis. Curr Opin Genet Dev 2001; 11:41-7.
27. Franzen B, Linder S, Uryu K, Alaiya AA, Hirano T, Kato H, et al. Expression of tropomyosin isoforms in benign and malignant human breast lesions. Br J Cancer 1996; 73:909-13.
28. Hughes JA, Cooke-Yarborough CM, Chadwick NC, Schevzov G, Arbuckle SM, Gunning P, et al. High-molecular-weight tropomyosins localize to the contractile rings of dividing CNS cells but are absent from malignant pediatric and adult CNS tumors. Glia 2003; 42:25-35.
29. Raval GN, Bharadwaj S, Levine EA, Willingham MC, Geary RL, Kute T, et al. Loss of expression of tropomyosin-1, a novel class II tumor suppressor that induces anoikis, in primary breast tumors. Oncogene 2003; 22:6194-203.
30. Pawlak G, McGarvey TW, Nguyen TB, Tomaszewski JE, Puthiyaveettil R, Malkowicz SB, et al. Alterations in tropomyosin isoform expression in human transitional cell carcinoma of the urinary bladder. Int J Cancer 2004; 110:368-73.
31. Varga AE, Stourman NV, Zheng Q, Safina AF, Quan L, Li X, et al. Silencing of the Tropomyosin-1 gene by DNA methylation alters tumor suppressor function of TGF[beta]. Oncogene 2005; 24:5043-52.
32. Bakin AV, Tomlinson AK, Bhowmick NA, Moses HL and Arteaga CL. Phosphatidylinositol 3-kinase function is required for TGFbeta-mediated epithelial to mesenchymal transition and cell migration. J Biol Chem 2000; 275:36803-10.
33. Juliano RL. Signal transduction by cell adhesion receptors and the cytoskeleton: Functions of Integrins, Cadherins, Selectins and Immunoglobulin-Superfamily Members. Annu Rev Pharmacol Toxicol 2002; 42:283-323.
34. Spector I, Shochet NR, Kashman Y and Groweiss A. Latrunculins: novel marine toxins that disrupt microfilament organization in cultured cells. Science 1983; 219:493-5.
35. Amann KJ and Pollard TD. Cellular regulation of actin network assembly. Curr Biol 2000; 10:728-30.
36. Brown MC and Turner CE. Paxillin: Adapting to Change. Physiol Rev 2004; 84:1315-39.
37. Nakamura K, Yano H, Uchida H, Hashimoto S, Schaefer E and Sabe H. Tyrosine Phosphorylation of Paxillin alpha Is Involved in Temporospatial Regulation of Paxillin-containing Focal Adhesion Formation and F-actin Organization in Motile Cells. J Biol Chem 2000; 275:27155-64.
38. Thuault S, Valcourt U, Petersen M, Manfioletti G, Heldin CH and Moustakas A. Transforming growth factor-beta employs HMGA2 to elicit epithelial- mesenchymal transition. J Cell Biol 2006; 174:175-83.
39. Pierreux CE, Nicolas FJ and Hill CS. Transforming Growth Factor beta-Independent Shuttling of Smad4 between the Cytoplasm and Nucleus. Mol Cell Biol 2000; 20:9041-54.
40. Chen HB, Rud JG, Lin K and Xu L. Nuclear Targeting of Transforming Growth Factor-{beta}-activated Smad Complexes. J Biol Chem 2005; 280:21329-36.
41. Schmierer B and Hill CS. Kinetic Analysis of Smad Nucleocytoplasmic Shuttling Reveals a Mechanism for Transforming Growth Factor {beta}-Dependent Nuclear Accumulation of Smads. Mol Cell Biol 2005; 25:9845-58.
42. Yashiroda Y and Yoshida M. Nucleo-cytoplasmic transport of proteins as a target for therapeutic drugs. Curr Med Chem 2003; 10:741-8.
43. Ogata H, Sato H, Takatsuka J and De Luca LM. Human breast cancer MDA-MB-231 cells fail to express the neurofibromin protein, lack its type I mRNA isoform and show accumulation of P-MAPK and activated Ras. Cancer Lett 2001; 172:159-64.
44. Rodriguez GC, Haisley C, Hurteau J, Moser TL, Whitaker R, Bast RC, et al. Regulation of Invasion of Epithelial Ovarian Cancer by Transforming Growth Factor-beta. Gynec Onc 2001; 80:245-53.
45. Spurzem JR, Sacco O, Rickard KA and Rennard SI. Transforming growth factor-beta increases adhesion but not migration of bovine bronchial epithelial cells to matrix proteins. J Lab Clin Med 1993; 122:92-102.
46. Tannenbaum JE, Waleh NS, Mauray F, Breuss J, Pytela R, Kramer RH, et al. Transforming growth factor beta1 inhibits fetal lamb ductus arteriosus smooth muscle cell migration. Pediatr Res 1995; 37:561-70.
47. Vial E, Sahai E and Marshall CJ. ERK-MAPK signaling coordinately regulates activity of Rac1 and RhoA for tumor cell motility. Cancer Cell 2003; 4:67-79.
48. Maeda M, Johnson KR and Wheelock MJ. Cadherin switching: essential for behavioral but not morphological changes during an epithelium-to-mesenchyme transition. J Cell Sci 2005; 118:873-87.
49. Fujita Y, Krause G, Scheffner M, Zechner D, Leddy HEM, Behrens J, et al. Hakai, a c-Cbl-like protein, ubiquitinates and induces endocytosis of the E-cadherin complex. Nat Cell Biol 2002; 4:222-31.
50. Khoury H, Naujokas MA, Zuo D, Sangwan V, Frigault MM, Petkiewicz S, et al. HGF Converts ErbB2/Neu Epithelial Morphogenesis to Cell Invasion. Mol Biol Cell 2005; 16:550-61.
51. MAPK and Epithelial Plasticity. J Biol Chem 2001; 276:46707-13.
52. Kaartinen V, Haataja L, Nagy A, Heisterkamp N and Groffen J. TGFbeta3-induced activation of RhoA/Rho-kinase pathway is necessary but not sufficient for epithelio-mesenchymal transdifferentiation: implications for palatogenesis. Int J Mol Med 2002; 9:563-70.
53. Masszi A, Di Ciano C, Sirokmany G, Arthur WT, Rotstein OD, Wang J, et al. Central role for Rho in TGFbeta1-induced alpha-smooth muscle actin expression during epithelial-mesenchymal transition. Am J Physiol Renal Physiol 2003; 284:911-24.
54. Ozdamar B, Bose R, Barrios-Rodiles M, Wang H-R, Zhang Y and Wrana JL. Regulation of the Polarity Protein Par6 by TGF{beta} Receptors Controls Epithelial Cell Plasticity. Science 2005; 307:1603-9.
55. Ridley AJ, Schwartz MA, Burridge K, Firtel RA, Ginsberg MH, Borisy G, et al. Cell Migration: Integrating Signals from Front to Back. Science 2003; 302:1704-9.
56. Chrzanowska-Wodnicka M and Burridge K. Rho-stimulated contractility drives the formation of stress fibers and focal adhesions. J Cell Biol 1996; 133:1403-15.
57. Cox EA, Sastry SK and Huttenlocher A. Integrin-mediated adhesion regulates cell polarity and membrane protrusion through the Rho family of GTPases. Mol Biol Cell 2001; 12:265-77.
58. Gimona M, Kazzaz JA and Helfman DM. Forced expression of tropomyosin 2 or 3 in v-Kiras-transformed fibroblasts results in distinct phenotypic effects. Proc Natl Acad Sci USA 1996; 93:9618-23.
59. Blanchoin L, Pollard TD and Hitchcock-DeGregori SE. Inhibition of the Arp2/3 complex-nucleated actin polymerization and branch formation by tropomyosin. Curr Biol 2001; 11:1300-4.
60. Friedl P and Wolf K. Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer 2003; 3:362-74.
61. Nakamura K, Yano H, Schaefer E and Sabe H. Different modes and qualities of tyrosine phosphorylation of Fak and Pyk2 during epithelial-mesenchymal transdifferentiation and cell migration: analysis of specific phosphorylation events using site-directed antibodies. Oncogene 2001; 20:2626-35.
62. Tumbarello DA, Brown MC, Hetey SE and Turner CE. Regulation of paxillin family members during epithelial-mesenchymal transformation: a putative role for paxillin {delta}. J Cell Sci 2005; 118:4849-63.
63. Bakin AV, Rinehart C, Tomlinson AK and Arteaga CL. p38 mitogen-activated protein kinase is required for TGF{beta}-mediated fibroblastic transdifferentiation and cell migration. J Cell Sci 2002; 115:3193-206.
64. Bhowmick NA, Ghiassi M, Bakin AV, Aakre M, Lundquist CA, Engel M, et al. TGFb mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism. Mol Biol Cell 2001; 12:27-36.
65. Hayashida T, deCaestecker M and Schnaper HW. Cross-talk between ERK MAP kinase and Smad-signaling pathways enhances TGFbeta; dependent responses in human mesangial cells. FASEB J 2003; 17:1576-8.
66. Roelen BAJ, Cohen OS, Raychowdhury MK, Chadee DN, Zhang Y, Kyriakis JM, et al. Phosphorylation of threonine 276 in Smad4 is involved in transforming growth factor-{beta}-induced nuclear accumulation. Am J Physiol Cell Physiol 2003; 285:823-30.
67. Yakymovych I, ten Dijke P, Heldin C-H and Souchelnytskyi S. Regulation of Smad signaling by protein kinase C. FASEB J 2001; 15:553-5.
68. Kojima K, Vickers SM, Adsay NV, Jhala NC, Kim H-G, Schoeb TR, et al. Inactivation of Smad4 Accelerates KrasG12D-Mediated Pancreatic Neoplasia. Cancer Res 2007; 67:8121-30.
69. Ijichi H, Chytil A, Gorska AE, Aakre ME, Fujitani Y, Fujitani S, et al. Aggressive pancreatic ductal adenocarcinoma in mice caused by pancreas-specific blockade of transforming growth factor-beta signaling in cooperation with active Kras expression. Genes Dev 2006; 20:3147-60.
70. Grady WM and Markowitz SD. Genetic and epigenetic alterations in colon cancer. Annu Rev Genomics Hum Genet 2002; 3:101-28.
71. Hendricks M and Weintraub H. Tropomyosin is decreased in transformed cells. Proc Natl Acad Sci USA 1981; 78:5633-7.
72. Zhu S, Si M-L, Wu H and Mo Y-Y. MicroRNA-21 Targets the Tumor Suppressor Gene Tropomyosin 1 (TPM1). J Biol Chem 2007; 282:14328-36.
73. Lin AW, Barradas M, Stone JC, van Aelst L, Serrano M and Lowe SW. Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling. Genes Dev 1998; 12:3008-19.
74. Bakin AV, Stourman NV, Sekhar KR, Rinehart C, Yan X, Meredith MJ, et al. Smad3-ATF3 signaling mediates TGFbeta suppression of genes encoding Phase II detoxifying proteins. Free Radic Biol Med 2005; 38:375-87.
75. Sherman B, Huang D, Tan Q, Guo Y, Bour S, Liu D, et al. DAVID Knowledgebase: a gene-centered database integrating heterogeneous gene annotation resources to facilitate high-throughput gene functional analysis. BMC Bioinformatics 2007; 8:426.
76. Reich M, Liefeld T, Gould J, Lerner J, Tamayo P and Mesirov JP. GenePattern 2.0. Nature Genetics 2006; 38:500-1.
77. Dennler S, Itoh S, Vivien D, ten Dijke P, Huet S and Gauthier JM. Direct binding of Smad3 and Smad4 to critical TGFbeta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J 1998; 17:3091-100.